- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow DAVID R Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 431905 [Title] => Science closing in on cloak of invisibility [Summary] =>WASHINGTON (AP) – They can't match Harry Potter yet, but scientists are moving closer to creating a real cloak of invisibility.
[DatePublished] => 2009-01-16 09:00:57 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) [1] => Array ( [ArticleID] => 152317 [Title] => Giant German pharma set to launch newest anti-"ED" preparation [Summary] => Leverkusen, Germany - First Pivotal Phase III data for vardenafil, Bayers new, highly selective phosphodiesterase-5 inhibitor for erectile dysfunction (ED), show statistically significant improvements in erectile function and consistency in response among up to 85 percent of the broad population of men treated. The data was presented last December at the Annual Meeting of the Sexual Medicine Society of North America (SMSNA) in Charleston, South Carolina/USA.
[DatePublished] => 2002-03-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
DAVID R
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 431905 [Title] => Science closing in on cloak of invisibility [Summary] =>WASHINGTON (AP) – They can't match Harry Potter yet, but scientists are moving closer to creating a real cloak of invisibility.
[DatePublished] => 2009-01-16 09:00:57 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => [SectionUrl] => [URL] => ) [1] => Array ( [ArticleID] => 152317 [Title] => Giant German pharma set to launch newest anti-"ED" preparation [Summary] => Leverkusen, Germany - First Pivotal Phase III data for vardenafil, Bayers new, highly selective phosphodiesterase-5 inhibitor for erectile dysfunction (ED), show statistically significant improvements in erectile function and consistency in response among up to 85 percent of the broad population of men treated. The data was presented last December at the Annual Meeting of the Sexual Medicine Society of North America (SMSNA) in Charleston, South Carolina/USA.
[DatePublished] => 2002-03-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => ) ) )
abtest
January 16, 2009 - 9:00am
March 1, 2002 - 12:00am
Recommended
The Insurance Commission has placed health maintenance organization Stotsenberg Healthcare Systems Inc.under conservatorship amid its inability to address requirements from the government.
3 days ago
Lotto Sep 21, 2024
EZ2/LVM - 20 17
SUERTRES - 9 2 4
6D Lotto - 6 5 4 8 7 3
6/42 - 20 10 14 23 3 38
P5,940,000.00
Grand Lotto - 6 20 5 28 29 10
P29,700,000.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66